Updates in SJS/TEN: collaboration, innovation, and community
Madeline E Marks,Ramya Krishna Botta,Riichiro Abe,Thomas M Beachkofsky,Isabelle Boothman,Bruce C Carleton,Wen-Hung Chung,Ricardo R Cibotti,Roni P Dodiuk-Gad,Christian Grimstein,Akito Hasegawa,Jay H Hoofnagle,Shuen-Iu Hung,Benjamin Kaffenberger,Daniela Kroshinsky,Rannakoe J Lehloenya,Michelle Martin-Pozo,Robert G Micheletti,Maja Mockenhaupt,Keisuke Nagao,Suman Pakala,Amy Palubinsky,Helena B Pasieka,Jonathan Peter,Munir Pirmohamed,Melissa Reyes,Hajirah N Saeed,Jeffery Shupp,Chonlaphat Sukasem,Jhih Yu Syu,Mayumi Ueta,Li Zhou,Wan-Chun Chang,Patrice Becker,Teresa Bellon,Kemberlee Bonnet,Gianpiero Cavalleri,James Chodosh,Anna K Dewan,Arturo Dominguez,Xinzhong Dong,Elena Ezhkova,Esther Fuchs,Jennifer Goldman,Sonia Himed,Simon Mallal,Alina Markova,Kerry McCawley,Allison E Norton,David Ostrov,Michael Phan,Arthur Sanford,David Schlundt,Daniel Schneider,Neil Shear,Kanade Shinkai,Eric Tkaczyk,Jason A Trubiano,Simona Volpi,Charles S Bouchard,Sherrie J Divito,Elizabeth J Phillips
DOI: https://doi.org/10.3389/fmed.2023.1213889
2023-10-11
Abstract:Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) is a predominantly drug-induced disease, with a mortality rate of 15-20%, that engages the expertise of multiple disciplines: dermatology, allergy, immunology, clinical pharmacology, burn surgery, ophthalmology, urogynecology, and psychiatry. SJS/TEN has an incidence of 1-5/million persons per year in the United States, with even higher rates globally. One of the challenges of SJS/TEN has been developing the research infrastructure and coordination to answer questions capable of transforming clinical care and leading to improved patient outcomes. SJS/TEN 2021, the third research meeting of its kind, was held as a virtual meeting on August 28-29, 2021. The meeting brought together 428 international scientists, in addition to a community of 140 SJS/TEN survivors and family members. The goal of the meeting was to brainstorm strategies to support the continued growth of an international SJS/TEN research network, bridging science and the community. The community workshop section of the meeting focused on eight primary themes: mental health, eye care, SJS/TEN in children, non-drug induced SJS/TEN, long-term health complications, new advances in mechanisms and basic science, managing long-term scarring, considerations for skin of color, and COVID-19 vaccines. The meeting featured several important updates and identified areas of unmet research and clinical need that will be highlighted in this white paper.